Optimal Timing and Site Selection for Minimally Invasive Surgery in Intracerebral Hemorrhage - Takeaways - MDSpire

Optimal Timing and Site Selection for Minimally Invasive Surgery in Intracerebral Hemorrhage

  • By

  • Yun-Xiang Zhou

  • Guo-Bin Zhang

  • April 1, 2026

  • 0 min

Share

  • 1

    The MIND trial provided significant insights into minimally invasive surgery for supratentorial intracerebral hemorrhage.

  • 2

    Despite achieving good technical results, the trial did not demonstrate benefits in mortality or disability at 180 days.

  • 3

    Surgery timing was relatively late, with a median onset-to-evacuation time of nearly 28 hours for most patients.

  • 4

    Most patients had deep hemorrhages, which may be less responsive to minimally invasive surgery compared to lobar cases.

  • 5

    Further analysis of surgical timing and hematoma location could enhance understanding of who benefits most from minimally invasive surgery.

Original Source(s)

Optimal Timing and Site Selection for Minimally Invasive Surgery in Intracerebral Hemorrhage

  • by Yun-Xiang Zhou, Guo-Bin Zhang

  • April 1, 2026

Related Content

Air Medical Transport of Patients with Spinal Disorders: A Comprehensive Review of Existing Evidence and Future Research Directions

Predicting Adverse Outcomes in Neurosurgical Patients Using Machine Learning: Exploring the Impact of Liver Function Indicators

Efficacy of Perampanel as a Monotherapy for Seizure Control During Awake Craniotomy in Glioma Patients